Arkuda Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Arkuda Therapeutics's estimated annual revenue is currently $5.9M per year.
- Arkuda Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Arkuda Therapeutics has 38 Employees.
- Arkuda Therapeutics grew their employee count by -16% last year.
Arkuda Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head Clinical Development | Reveal Email/Phone |
2 | SVP, Head Discovery | Reveal Email/Phone |
3 | VP, Medicinal Chemistry | Reveal Email/Phone |
4 | VP, Finance | Reveal Email/Phone |
5 | Director, Medicinal Chemistry | Reveal Email/Phone |
6 | Senior Director Human Resources | Reveal Email/Phone |
7 | Co-Founder and Chief Technology Officer | Reveal Email/Phone |
8 | Associate Director, Toxicology | Reveal Email/Phone |
9 | Chief Business Officer | Reveal Email/Phone |
10 | Director, Pharmacology | Reveal Email/Phone |
Arkuda Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Arkuda Therapeutics?
Arkuda Therapeutics is a biotechnology company leveraging new insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease.
keywords:N/A
N/A
Total Funding
38
Number of Employees
$5.9M
Revenue (est)
-16%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Arkuda Therapeutics News
2022-02-22 - Arkuda Reels in Another $64M to Disrupt Neurodegenerative ...
The company is developing therapeutic compounds that treat neurodegenerative diseases in which genetically linked biological dysfunction of a...
2022-02-22 - Arkuda Therapeutics Raises $64 Million Series B Financing to ...
Arkuda Therapeutics is a biotechnology company applying insights into lysosomal and microglial biology to drive the development of medicines to...
2022-02-22 - Arkuda Therapeutics Raises $64M in Series B Financing
Arkuda Therapeutics, a Watertown MA-based biotechnology company, raised $64M in Series B funding. The round was led by Cormorant Asset...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4M | 38 | 0% | $10M |
#2 | $5.5M | 38 | -7% | N/A |
#3 | $4.4M | 38 | N/A | N/A |
#4 | $7.5M | 38 | 0% | N/A |
#5 | $4.4M | 38 | 46% | N/A |